Conmed (CNMD) Shares Outstanding (Weighted Average) (2010 - 2026)

Conmed has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $30.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 1.24% year-over-year to $30.6 million; the trailing twelve-month figure through Mar 2026 stood at $30.6 million (down 1.24% YoY), and the FY2025 full-year result was $31.0 million, up 0.62% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $30.6 million, down from $31.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $31.0 million in Q4 2025, with the low at $29.4 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $30.6 million across 5 years, with a median of $30.7 million in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) gained 4.43% — and 2026, when it fell 1.24%.
• Conmed's Shares Outstanding (Weighted Average) stood at $30.0 million in 2022, then grew by 2.09% to $30.7 million in 2023, then increased by 0.58% to $30.8 million in 2024, then rose by 0.62% to $31.0 million in 2025, then decreased by 1.44% to $30.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $30.6 million (Q1 2026), $31.0 million (Q4 2025), and $31.0 million (Q3 2025), per Business Quant data.